BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31481169)

  • 1. Huntington's disease: Brain imaging in Huntington's disease.
    Johnson EB; Gregory S
    Prog Mol Biol Transl Sci; 2019; 165():321-369. PubMed ID: 31481169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Magnetic Resonance Imaging in Huntington's Disease.
    Wilson H; Dervenoulas G; Politis M
    Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
    Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
    Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging.
    Gatto RG; Weissmann C; Amin M; Angeles-López QD; García-Lara L; Castellanos LCS; Deyoung D; Segovia J; Mareci TH; Uchitel OD; Magin RL
    Neurobiol Aging; 2021 Jun; 102():32-49. PubMed ID: 33765430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Magnetic Resonance Imaging in Huntington's Disease.
    Gregory S; Scahill RI
    Int Rev Neurobiol; 2018; 142():381-408. PubMed ID: 30409260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease.
    Garcia-Gorro C; Llera A; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; Beckmann CF; de Diego-Balaguer R; Camara E
    Neuroimage Clin; 2019; 23():101900. PubMed ID: 31255947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor network structure and function are associated with motor performance in Huntington's disease.
    Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
    J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of white matter pathology in premanifest huntington's disease.
    Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
    Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.
    Steventon JJ; Trueman RC; Ma D; Yhnell E; Bayram-Weston Z; Modat M; Cardoso J; Ourselin S; Lythgoe M; Stewart A; Rosser AE; Jones DK
    Sci Rep; 2016 Sep; 6():32423. PubMed ID: 27581950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional changes of the visual cortex in early Huntington's disease.
    Coppen EM; Grond JV; Hafkemeijer A; Barkey Wolf JJH; Roos RAC
    Hum Brain Mapp; 2018 Dec; 39(12):4776-4786. PubMed ID: 30144208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental Whole Brain White Matter Alterations in Transgenic Huntington's Disease Monkey.
    Meng Y; Jiang J; Bachevalier J; Zhang X; Chan AW
    Sci Rep; 2017 Mar; 7(1):379. PubMed ID: 28336929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging in Huntington's Disease.
    Gregory S; Scahill RI; Rees G; Tabrizi S
    Methods Mol Biol; 2018; 1780():303-328. PubMed ID: 29856026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network spread determines severity of degeneration and disconnection in Huntington's disease.
    Poudel GR; Harding IH; Egan GF; Georgiou-Karistianis N
    Hum Brain Mapp; 2019 Oct; 40(14):4192-4201. PubMed ID: 31187915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.